NO20016301L - Terapeutiske midler - Google Patents

Terapeutiske midler

Info

Publication number
NO20016301L
NO20016301L NO20016301A NO20016301A NO20016301L NO 20016301 L NO20016301 L NO 20016301L NO 20016301 A NO20016301 A NO 20016301A NO 20016301 A NO20016301 A NO 20016301A NO 20016301 L NO20016301 L NO 20016301L
Authority
NO
Norway
Prior art keywords
therapeutic agents
human
compound
formula
effective amount
Prior art date
Application number
NO20016301A
Other languages
English (en)
Other versions
NO20016301D0 (no
Inventor
Alan Martin
David John Heal
Original Assignee
Knoll Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Knoll Gmbh filed Critical Knoll Gmbh
Publication of NO20016301L publication Critical patent/NO20016301L/no
Publication of NO20016301D0 publication Critical patent/NO20016301D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Metode for behandling av overvekt og tilhørende ko-morbide tilstander hos et menneske med behov for slik behandling som omfatter administrering til mennesket av en terapeutisk effektiv mengde av en forbindelse med formel (I), omfattende enantiomere og farmasøytisk akseptable salter derav, hvori Ri og Ruavhengig er H eller metyl og en terapeutisk effektiv mengde av lipaseinhibitor, med unntak av orlistat;. hvori forbindelsen med formel (I) og lipaseinhibitoren administreres simulant, separat eller sekvensielt.
NO20016301A 1999-06-24 2001-12-21 Terapeutiske midler NO20016301D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9914742.3A GB9914742D0 (en) 1999-06-24 1999-06-24 Therapeutic agents
PCT/EP2000/005544 WO2001000187A2 (en) 1999-06-24 2000-06-16 Pharmaceutical composition containing sibutramine and a lipase inhibitor

Publications (2)

Publication Number Publication Date
NO20016301L true NO20016301L (no) 2001-12-21
NO20016301D0 NO20016301D0 (no) 2001-12-21

Family

ID=10855953

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20016301A NO20016301D0 (no) 1999-06-24 2001-12-21 Terapeutiske midler

Country Status (20)

Country Link
EP (1) EP1189638A2 (no)
JP (1) JP2003503344A (no)
KR (1) KR20020012293A (no)
CN (1) CN1365287A (no)
AU (1) AU5815100A (no)
BG (1) BG106209A (no)
BR (1) BR0011884A (no)
CA (1) CA2376213A1 (no)
CZ (1) CZ20014614A3 (no)
GB (1) GB9914742D0 (no)
HK (1) HK1050476A1 (no)
HU (1) HUP0201880A3 (no)
IL (1) IL147078A0 (no)
MX (1) MXPA01013023A (no)
NO (1) NO20016301D0 (no)
PL (1) PL352387A1 (no)
SK (1) SK18822001A3 (no)
TR (1) TR200103704T2 (no)
WO (1) WO2001000187A2 (no)
ZA (1) ZA200110046B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6399826B1 (en) * 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
US7089666B2 (en) * 2003-06-06 2006-08-15 The Regents Of The University Of California Microfabricated vertical comb actuator using plastic deformation
JP2010503709A (ja) 2006-09-15 2010-02-04 レビバ ファーマシューティカルズ，インコーポレーテッド シクロアルキルメチルアミンの合成、使用方法および組成物
CN101890017A (zh) * 2009-05-22 2010-11-24 北京奥萨医药研究中心有限公司 含有西布曲明和他汀类降脂药物的药物组合物及其用途
WO2012003501A2 (en) 2010-07-02 2012-01-05 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
US9238625B2 (en) 2011-12-30 2016-01-19 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives

Also Published As

Publication number Publication date
CA2376213A1 (en) 2001-01-04
AU5815100A (en) 2001-01-31
CZ20014614A3 (cs) 2004-02-18
GB9914742D0 (en) 1999-08-25
PL352387A1 (en) 2003-08-25
JP2003503344A (ja) 2003-01-28
BG106209A (en) 2002-09-30
CN1365287A (zh) 2002-08-21
ZA200110046B (en) 2003-03-06
HUP0201880A3 (en) 2003-03-28
KR20020012293A (ko) 2002-02-15
NO20016301D0 (no) 2001-12-21
TR200103704T2 (tr) 2002-05-21
SK18822001A3 (sk) 2003-04-01
EP1189638A2 (en) 2002-03-27
HK1050476A1 (zh) 2003-06-27
BR0011884A (pt) 2003-08-12
HUP0201880A2 (hu) 2002-12-28
WO2001000187A3 (en) 2001-11-15
MXPA01013023A (es) 2003-08-01
IL147078A0 (en) 2002-08-14
WO2001000187A2 (en) 2001-01-04

Similar Documents

Publication Publication Date Title
NO973516L (no) Behandling av urininkontinens ved anvendelse av (S)-oksybutynin og (S)-desetyloksybutynin
NO20003313D0 (no) Terapeutiske midler
EP0244083A3 (en) Amino acid derivatives
WO1997005862A3 (en) Use of basic amino acids and derivatives for lowering ceramide levels
NO20016301L (no) Terapeutiske midler
PL360492A1 (en) Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
MXPA01012936A (es) Composicion farmaceutica que contiene sibutramina y orlistat.
NO20042758L (no) Fremgangsmate for behandling av en pasient som krever analgesi.
NO20052313L (no) Vandig farmasoytisk formulering omfattende trombininhibitorer melagatran og anvendelse av formuleringen for fremstilling av et medikament for anvendelse i nasal administrering i behandling av
IT1293583B1 (it) Uso dell'acido gammaidrossibutirrico per il trattamento delle sindromi demenziali
NO933091L (no) Anvendelse av 1-aryl-3-(4-piperidyl)-indolderivater ved behandling av kognitive forstyrrelser
NO20016000D0 (no) Aminotetralin-derivat for terapien av kardiovaskul¶re sykdommer
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
HUP0200148A2 (hu) N-(3',4'-dimetoxi-cinnamoil)antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére
NO329889B1 (no) Anvendelse av et imidazolderivat til fremstilling av et legemiddel til a forhindre eller behandle hypotensjon og sjokk som skyldes lav perifer motstand, eller kardiopulmonaer gjenopplivning
HUP0200129A2 (hu) N-(3'4'-dimetoxi-cinnamoil)-antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére
MX9605153A (es) Agentes farmaceuticos para el tratamiento de enfermedades inflamatorias cronicas y agudas.
NO951865L (no) Quinuclidin-derivat som substans-P antagonist
PE20001336A1 (es) Composicion que contiene un miorelajante y un antiinflamatorio no esteroideo para el tratamiento de afecciones dolorosas asociadas a contracturas o espamos musculares
MX9704887A (es) Composiciones farmaceuticas para el tratamiento de trastornos depresivos.
UA43800A (uk) Спосіб лікування перфоративної виразки дванадцятипалої кишки

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application